These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3330 related articles for article (PubMed ID: 9278044)

  • 21. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
    Braak H; Sandmann-Keil D; Gai W; Braak E
    Neurosci Lett; 1999 Apr; 265(1):67-9. PubMed ID: 10327208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
    Tofaris GK; Razzaq A; Ghetti B; Lilley KS; Spillantini MG
    J Biol Chem; 2003 Nov; 278(45):44405-11. PubMed ID: 12923179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.
    Arawaka S; Saito Y; Murayama S; Mori H
    Neurology; 1998 Sep; 51(3):887-9. PubMed ID: 9748051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-synuclein and Parkinson's disease.
    Golbe LI
    Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
    [No Abstract]   [Full Text] [Related]  

  • 25. 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains.
    Kawamoto Y; Akiguchi I; Nakamura S; Honjyo Y; Shibasaki H; Budka H
    J Neuropathol Exp Neurol; 2002 Mar; 61(3):245-53. PubMed ID: 11895039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent advances in the neuropathological evaluation of Alzheimer's disease: the importance of alpha-synuclein].
    Hamilton RL
    Rev Neurol; 2002 Oct 16-31; 35(8):765-7. PubMed ID: 12402231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique.
    Sandmann-Keil D; Braak H; Okochi M; Haass C; Braak E
    Acta Neuropathol; 1999 Nov; 98(5):461-4. PubMed ID: 10541868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. alpha-Synuclein filaments bind the transcriptional regulator HMGB-1.
    Lindersson EK; Højrup P; Gai WP; Locker D; Martin D; Jensen PH
    Neuroreport; 2004 Dec; 15(18):2735-9. PubMed ID: 15597044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?
    Münch G; Lüth HJ; Wong A; Arendt T; Hirsch E; Ravid R; Riederer P
    J Chem Neuroanat; 2000 Dec; 20(3-4):253-7. PubMed ID: 11207423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha synuclein in neurodegenerative disorders: murderer or accomplice?
    Mezey E; Dehejia A; Harta G; Papp MI; Polymeropoulos MH; Brownstein MJ
    Nat Med; 1998 Jul; 4(7):755-7. PubMed ID: 9662355
    [No Abstract]   [Full Text] [Related]  

  • 31. Lewy pathology in gastric and duodenal biopsies in Parkinson's Disease.
    Pouclet H; Lebouvier T; Coron E; Neunlist M; Derkinderen P
    Mov Disord; 2012 May; 27(6):708. PubMed ID: 22649005
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple-system atrophy: a new alpha-synuclein disease?
    Gai WP; Power JH; Blumbergs PC; Blessing WW
    Lancet; 1998 Aug; 352(9127):547-8. PubMed ID: 9716068
    [No Abstract]   [Full Text] [Related]  

  • 33. Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation.
    Broe M; Shepherd CE; Mann DM; Milward EA; Gai WP; Thiel E; Halliday GM
    Neurotox Res; 2005; 7(1-2):69-76. PubMed ID: 15639799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication.
    Miller DW; Hague SM; Clarimon J; Baptista M; Gwinn-Hardy K; Cookson MR; Singleton AB
    Neurology; 2004 May; 62(10):1835-8. PubMed ID: 15159488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zeroing in on neurodegenerative α-synuclein.
    Kingwell K
    Nat Rev Drug Discov; 2017 May; 16(6):371-373. PubMed ID: 28559555
    [No Abstract]   [Full Text] [Related]  

  • 36. Lewy bodies: purification from diffuse Lewy body disease brains.
    Iwatsubo T; Yamaguchi H; Fujimuro M; Yokosawa H; Ihara Y; Trojanowski JQ; Lee VM
    Ann N Y Acad Sci; 1996 Jun; 786():195-205. PubMed ID: 8687019
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies.
    Oláh J; Tokési N; Vincze O; Horváth I; Lehotzky A; Erdei A; Szájli E; Medzihradszky KF; Orosz F; Kovács GG; Ovádi J
    FEBS Lett; 2006 Oct; 580(25):5807-14. PubMed ID: 17027006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attack on amyloid.
    Kahle PJ; De Strooper B
    EMBO Rep; 2003 Aug; 4(8):747-51. PubMed ID: 12897797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure.
    Kaufmann H; Hague K; Perl D
    Neurology; 2001 Apr; 56(7):980-1. PubMed ID: 11294945
    [No Abstract]   [Full Text] [Related]  

  • 40. [Propagation of polyglutamine agregates in normal cells].
    Offner N; Vazquez R; Néri C
    Med Sci (Paris); 2009 Oct; 25(10):773-4. PubMed ID: 19849968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 167.